Enriched Endogenous Omega-3 Polyunsaturated Fatty Acids Protect Cortical Neurons from Experimental Ischemic Injury

Mol Neurobiol. 2016 Nov;53(9):6482-6488. doi: 10.1007/s12035-015-9554-y. Epub 2015 Nov 26.

Abstract

Omega-3 polyunsaturated fatty acids (n-3 PUFAs) exert therapeutic potential in a variety of neurological disorders, including ischemic stroke. However, the underlying mechanisms still lack investigation. Here, we report that cultured cortical neurons isolated from fat-1 mice with high endogenous n-3 PUFAs were tolerant to oxygen-glucose deprivation/reperfusion (OGD/R) injury. Fat-1 neurons exhibited significantly attenuated reactive oxygen species (ROS) activation induced by OGD/R injury, upregulated antiapoptotic proteins Bcl-2 and Bcl-xL, and reduced cleaved caspase-3. Exogenous administration of docosahexaenoic acid (DHA), a major component of the n-3 PUFA family, resulted in similar protective effects on cultured cortex neurons. We further verified the protective effects of n-3 PUFAs in vivo, using a mini ischemic model with a reproducible cortical infarct and manifest function deficits by occlusion of the distal branch of the middle cerebral artery with focused femtosecond laser pulses. The Fat-1 animals showed decreased ROS expression and higher level of glutathione in the injured brain, associated with improved functional recovery. We therefore provide evidence that n-3 PUFAs exert their protective effects against ischemic injury both in vitro and in vivo, partly through inhibiting ROS activation.

Keywords: DHA; Ischemia; Omega-3 polyunsaturated fatty acids; ROS.

MeSH terms

  • Animals
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / pathology*
  • Brain Ischemia / physiopathology
  • Cadherins / metabolism
  • Cells, Cultured
  • Cerebral Cortex / pathology*
  • Disease Models, Animal
  • Docosahexaenoic Acids / administration & dosage
  • Docosahexaenoic Acids / pharmacology
  • Docosahexaenoic Acids / therapeutic use
  • Fatty Acids, Omega-3 / pharmacology
  • Fatty Acids, Omega-3 / therapeutic use*
  • Female
  • Glucose / deficiency
  • Glutathione / metabolism
  • Mice, Inbred C57BL
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology*
  • Neuroprotection / drug effects
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use*
  • Oxygen
  • Reactive Oxygen Species / metabolism
  • Recovery of Function / drug effects
  • Reperfusion Injury / drug therapy
  • Reperfusion Injury / pathology
  • Up-Regulation / drug effects

Substances

  • Cadherins
  • Fatty Acids, Omega-3
  • Neuroprotective Agents
  • Reactive Oxygen Species
  • fat1 protein, mouse
  • Docosahexaenoic Acids
  • Glutathione
  • Glucose
  • Oxygen